**Patient Discharge Summary**

**Patient Information**

* Name: John Doe
* Date of Birth: March 12, 1990
* Admission Date: March 10, 2023
* Discharge Date: March 15, 2023

**Chief Complaint**

John Doe, a 33-year-old male, was admitted to the infectious diseases unit on March 10, 2023, with a chief complaint of fever, cough, and body aches, which began on March 8, 2023. He presented with a temperature of 103째F (39.4째C), cough productive of yellow sputum, and substernal chest pain.

**History of Present Illness**

The patient reported a 2-day history of symptoms, which initially started with a sore throat, followed by fever, cough, and body aches. He denied any recent travel or contact with anyone with similar symptoms. He also denied any underlying medical conditions or allergies.

**Physical Examination**

Upon admission, the patient was found to be in moderate distress, with a temperature of 103째F (39.4째C), pulse of 120 beats per minute, and blood pressure of 140/90 mmHg. He had a productive cough, with yellow sputum, and substernal chest pain. His oxygen saturation was 95% on room air.

**Diagnostic Evaluation**

A comprehensive diagnostic evaluation was performed, including a rapid antigen test and RT-PCR test, which confirmed the diagnosis of influenza A (H3N2) on March 11, 2023. A chest x-ray was also performed, which showed bilateral interstitial infiltrates, consistent with primary influenza pneumonia.

**Treatment**

The patient was treated with a combination of symptomatic and antiviral therapies. He was started on oral oseltamivir 75 mg twice a day on March 11, 2023, and continued for a total of 5 days. He also received acetaminophen 325 mg every 6 hours as needed for fever and pain management. Additionally, he was given a humidifier to help relieve cough and congestion.

**Course of Hospitalization**

The patient's condition improved gradually over the course of his hospital stay. His fever resolved by March 13, 2023, and his cough and body aches began to subside. He was able to tolerate oral medications and was ambulating with assistance. However, he continued to require oxygen therapy and was monitored closely for any signs of complications.

**Discharge Instructions**

The patient was discharged on March 15, 2023, with the following instructions:

* Continue taking oseltamivir 75 mg twice a day for a total of 5 days.
* Take acetaminophen 325 mg every 6 hours as needed for fever and pain management.
* Use a humidifier to help relieve cough and congestion.
* Rest and avoid strenuous activities for the next 2-3 days.
* Follow up with his primary care physician in 2-3 days to ensure resolution of symptoms.

**Medications**

* Oseltamivir 75 mg orally twice a day for 5 days
* Acetaminophen 325 mg every 6 hours as needed
* Humidifier for cough and congestion relief

**Allergies**

* None reported

**Social History**

* The patient is a non-smoker and does not consume alcohol.

**Family History**

* The patient has no known family history of allergies or medical conditions.

**Review of Systems**

* The patient's review of systems was otherwise unremarkable.

**Final Diagnosis**

* Influenza A (H3N2)

**Discharge Summary**

The patient, John Doe, was admitted to the infectious diseases unit on March 10, 2023, with a chief complaint of fever, cough, and body aches, which were confirmed to be caused by influenza A (H3N2). He was treated with oseltamivir and acetaminophen, and his condition improved gradually over the course of his hospital stay. He was discharged on March 15, 2023, with instructions to continue taking oseltamivir and acetaminophen, and to rest and avoid strenuous activities for the next 2-3 days.